IP Library Granted Patent US 12,397,152
Granted Patent B2
US 12,397,152 · App. 18/375,702 · Granted Aug 26, 2025

Systems and methods for implanting a medical device

Inventors: Thomas B. Eby (Mountain View, CA); Alan Klenk (San Jose, CA)
Assignee: PACESETTER, INC.
A61N1/05A61N1/37205A61N1/3756A61B2017/00473A61B17/3468A61M25/0082A61N2001/058
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,397,152
App. No.
18/375,702
Granted
Aug 26, 2025
Kind
B2
Abstract

In at least one embodiment, a system and method for implanting an implantable medical device (IMD) within a patient may include an IMD including a housing and an attachment member, and a delivery catheter including a tethering snare that is configured to be selectively extended out of the delivery catheter and retracted into the delivery catheter. In at least one embodiment, a system and method for implanting an implantable medical device (IMD) within a patient may include an IMD including a housing and an attachment member, wherein the attachment member includes a central passage connected to a connection chamber, and a delivery catheter including first and second tethers that may be moved outwardly from and retracted into the delivery catheter.

Claims (28)

1. A delivery system, comprising:

a control device; and

a plurality of tethers operatively coupled to the control device, wherein the plurality of tethers are configured to fit through a central passage of an implantable medical device (IMD) in a first mode, wherein the plurality of tethers are configured to not fit through the central passage in a second mode, and wherein the delivery system is configured to test whether the IMD is connected to an implant site in the second mode.

2. The delivery system of claim 1 , wherein the plurality of tethers include a locking tether having a protuberance at a distal end of a tether.

3. The delivery system of claim 2 , wherein the protuberance has a larger diameter than the tether.

4. The delivery system of claim 1 , wherein the plurality of tethers include a locking tether and a flexible tether, and wherein the locking tether is locked in a connection chamber of the IMD in the second mode.

5. The delivery system of claim 4 , wherein a first distal end of the flexible tether is proximal to a second distal end of the locking tether in the first mode.

6. The delivery system of claim 5 , wherein the first distal end is distal to the second distal end in the second mode.

7. An implantable medical device (IMD) system, comprising:

an IMD including an attachment member having a central passage; and

a delivery system including a plurality of tethers operatively coupled to a control device, wherein the plurality of tethers are configured to fit through the central passage in a first mode, wherein the plurality of tethers are configured to not fit through the central passage in a second mode, and wherein the delivery system is configured to test whether the IMD is connected to an implant site in the second mode.

8. The IMD system of claim 7 , wherein the plurality of tethers include a locking tether having a protuberance at a distal end of a tether.

9. The IMD system of claim 8 , wherein the protuberance has a larger diameter than the tether.

10. The IMD system of claim 7 , wherein the plurality of tethers include a locking tether and a flexible tether, and wherein the locking tether is locked in a connection chamber of the IMD in the second mode.

11. The IMD system of claim 10 , wherein a first distal end of the flexible tether is proximal to a second distal end of the locking tether in the first mode.

12. The IMD system of claim 11 , wherein the first distal end is distal to the second distal end in the second mode.

13. A method, comprising:

advancing an implantable medical device (IMD) system to an implant site, wherein the IMD system includes a delivery system tethered to an IMD;

affix the IMD to the implant site;

remove the delivery system from the implant site, wherein the delivery system remains tethered to the IMD in a mode after removal; and

test whether the IMD is connected to the implant site in the mode.

14. The method of claim 13 , wherein testing whether the IMD is connected to the implant site includes testing whether the IMD is physically connected to the implant site.

15. The method of claim 13 , wherein testing whether the IMD is connected to the implant site includes testing whether the IMD is electrically connected to the implant site.

16. The method of claim 13 further comprising removing, in response to the IMD being connected to the implant site, a plurality of tethers from a central passage of the IMD.

17. The method of claim 13 further comprising removing, in response to the IMD not being connected to the implant site, the IMD from the implant site.

18. The method of claim 13 , wherein the delivery system is tethered to the IMD by a plurality of tethers including a locking tether having a protuberance at a distal end of a tether, and wherein the protuberance has a larger diameter than the tether.

19. The method of claim 13 , wherein the delivery system is tethered to the IMD by a plurality of tethers including a locking tether and a flexible tether, and wherein the locking tether is locked in a connection chamber of the IMD in the second mode.

20. The method of claim 19 , wherein the first distal end is distal to the second distal end in the second mode.

Assignments (2)
MERGER Recorded Oct 4, 2024
From: NANOSTIM, INC.
To: PACESETTER, INC.
Reel/Frame 068806/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2024
From: EBY, THOMAS B.; KLENK, ALAN
To: NANOSTIM, INC.
Reel/Frame 066741/0940 →
Continuity (4)
Continuation 17316434 · May 10, 2021
Division 16189891 · Nov 13, 2018
Division 14481818 · Sep 9, 2014
Related Publication 20240024662A1 · Jan 25, 2024
References Cited (31)
US 4744366A · Jang · 1988 [cited by applicant]
US 5226889A · Sheiban · 1993 [cited by applicant]
US 5669924A · Shaknovich · 1997 [cited by applicant]
US 6059719A · Yamamoto et al. · 2000 [cited by applicant]
US 6149664A · Kurz · 2000 [cited by applicant]
US 6770092B2 · Richter · 2004 [cited by applicant]
US 7445610B2 · Adams et al. · 2008 [cited by applicant]
US 7757692B2 · Alferness et al. · 2010 [cited by applicant]
US 8377044B2 · Coe et al. · 2013 [cited by applicant]
US 9539423B2 · Bonner et al. · 2017 [cited by applicant]
US 10441777B2 · Paspa et al. · 2019 [cited by applicant]
US 20060009800A1 · Christianson et al. · 2006 [cited by applicant]
US 20060105613A1 · Carroll · 2006 [cited by applicant]
US 20060243106A1 · Kikuchi · 2006 [cited by applicant]
US 20070219611A1 · Krever et al. · 2007 [cited by applicant]
US 20080243106A1 · Coe et al. · 2008 [cited by applicant]
US 20090204170A1 · Hastings et al. · 2009 [cited by applicant]
US 20110270340A1 · Pellegrini et al. · 2011 [cited by applicant]
US 20120095539A1 · Khairkhahan et al. · 2012 [cited by applicant]
US 20120165827A1 · Khairkhahan et al. · 2012 [cited by applicant]
US 20120197373A1 · Khairkhahan et al. · 2012 [cited by applicant]
US 20130012925A1 · Berthiaume et al. · 2013 [cited by applicant]
US 20130053921A1 · Bonner et al. · 2013 [cited by applicant]
US 20140074114A1 · Khairkhahan et al. · 2014 [cited by applicant]
US 20140277351A1 · Ridgley et al. · 2014 [cited by applicant]
US 20150051611A1 · Schmidt et al. · 2015 [cited by applicant]
US 20170113035A1 · Bonner et al. · 2017 [cited by applicant]
Amendment filed Mar. 1, 2018; Related U.S. Appl. No. 14/481,818. [cited by applicant]
Final Office Action mailed Jul. 13, 2018; Related U.S. Appl. No. 14/481,818. [cited by applicant]
Non-Final Office Action mailed Jun. 2, 2017; Related U.S. Appl. No. 14/481,799. [cited by applicant]
Non-Final Office Action mailed Dec. 27, 2017; Related U.S. Appl. No. 14/481,818. [cited by applicant]